Gregory Alan Korbel
VP of Business Dev't, Aprea Therapeutics, Inc.
Companies
- Aprea Therapeutics, Inc.Chief operating officer Jun 7, 2022 to Aug 1, 20221
- Aprea Therapeutics, Inc.Board member Mar 14, 2022 to Jun 7, 20222
- Aprea Therapeutics, Inc.VP of Business Dev't Oct 2, 2019 to Mar 14, 20223
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aprea Therapeutics, Inc. APRE45,762 shares4$25.8K at $0.56Jul 28, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 28, 2022Granted 24,300 shares of Aprea Therapeutics, Inc.4
- Jun 3, 2022Shares withheld for tax 8,390 shares at $0.81 of Aprea Therapeutics, Inc.5
- Mar 10, 2022Shares withheld for tax 1,989 shares at $1.82 of Aprea Therapeutics, Inc.6
- Mar 10, 2022Granted 16,000 shares of Aprea Therapeutics, Inc.6
- Feb 25, 2022Shares withheld for tax 1,326 shares at $1.74 of Aprea Therapeutics, Inc.7
- Dec 1, 2021Sold 27,500 shares at $3.96 of Aprea Therapeutics, Inc.8
- Dec 1, 2021Exercised options 27,500 shares at $0.92 of Aprea Therapeutics, Inc.8
- Nov 1, 2021Sold 27,500 shares at $5.00 of Aprea Therapeutics, Inc.9
- Nov 1, 2021Exercised options 27,500 shares at $0.92 of Aprea Therapeutics, Inc.9
- Oct 1, 2021Sold 27,500 shares at $4.89 of Aprea Therapeutics, Inc.10
- Oct 1, 2021Exercised options 27,500 shares at $0.92 of Aprea Therapeutics, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jun 7, 2022
- 6SEC EDGARForm 4 filed Mar 14, 2022
- 7SEC EDGARForm 4 filed Mar 1, 2022
- 8SEC EDGARForm 4 filed Dec 3, 2021
- 9SEC EDGARForm 4 filed Nov 3, 2021
- 10SEC EDGARForm 4 filed Oct 5, 2021